National Cancer Center Hospital East at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
National Cancer Center Hospital East takes part in 10 sessions at ESMO 2026 in Madrid. Its program centres on gastroesophageal cancer, from HER2-positive disease and treatment resistance to precision oncology in advanced gastric cancer. Other sessions cover circulating tumour DNA to find residual disease after colorectal cancer surgery, retreatment of BRAF V600E-mutant colorectal cancer and arterial embolization for painful bone metastases.
| Organization | ESMO 2026 Attendance |
|---|---|
National Cancer Center Hospital East Kashiwa, Japan | |
Hospital of Japan's National Cancer Center in Kashiwa, near Tokyo, focused on cancer treatment and early-phase trials. | Abstract Fri Oct 23 13:30–13:40 Abstract Fri Oct 23 16:15–16:20 Talk Sat Oct 24 09:10–09:30 Treatment sequence and resistance mechanism to targeted therapy and immunotherapy Gastrointestinal cancers Abstract Sat Oct 24 14:55–15:00 Talk Sat Oct 24 19:30–19:45 Resistance pathways and related challenges: Options and breakthroughs in later line therapies Gastrointestinal cancersBiomarkers & precision oncology Abstract Sun Oct 25 14:55–15:05 Abstract Sun Oct 25 17:30–17:35 Chair Mon Oct 26 08:30–10:00 Advancing targeted and immunotherapeutic strategies in upper GI cancer Gastrointestinal cancers Satellite Mon Oct 26 13:30–13:45 Plenary: Precision oncology in focus: the evolving era in advanced GC / GEJC Gastrointestinal cancers Satellite Mon Oct 26 13:45–13:50 Audience Q&A Gastrointestinal cancers Satellite Mon Oct 26 13:50–14:20 Satellite Mon Oct 26 14:20–14:25 Audience Q&A Gastrointestinal cancers Talk Tue Oct 27 11:20–11:40 |
Instantly find 20 buyers from National Cancer Center Hospital East
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction